Marcus Bosenberg
Dermatopathology · Burlington, VTNPI 1679595094
Payments from drug & device makers
$807,402in general payments, 2019–2025
Across 5 payments — averaging $161,480 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$805K
- E.r. Squibb & Sons, L.L.C.$2K
What the payments were for
- Consulting fees$1,966100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $805,436 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,966 |
How this compares
Too few dermatopathology providers in Vermontto place this figure against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.